Germany Archives

News and Trends 5 Nov 2015

German Bioinformatics Start-Up wants to Change Studies of GMO Crops

High-Tech Grüenderfonds (HTGF) has invested in a spin-off from the Max Planck Institute for Developmental Biology and University of Tübingen. Computomics’ has a pioneering agricultural project involving next generation sequencing (NGS) of GMO crops. Computomics is the biotech which has caught HTGF’s interest. Based in Tübingen (Germany), this bio-informatics start-up tackle genomic analysis of agricultural […]

November 5, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 5 Nov 2015

Damn, that was BIO-Europe 2015 in Munich!

We are now back in Berlin after three (intense) days at BIO-Europe 2015 in Munich. It was definitely a great fair. We covered the event with articles and videos to give you a live insight, (almost) as if you were there. Everything is below 😉 Day 1 : EU’s biggest Biotech Fair, BIO-Europe 2015, […]

November 5, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 4 Nov 2015

€1.37Bn Deal for Sanofi with Germany’s Fastest Growing mRNA Cancer Biotech

Sanofi is now the latest Biotech lining up to partner with BioNTech from Mainz (Germany), for license of their mRNA Immuno-oncology platform in a€1.37Bn long-term development deal. Novel mRNA targets in Immuno-onology is a top-shelf cancer R&D area, with Germany’s CureVac also attracting another €100M yesterday for their mRNA platform (which targets lung and prostate […]

November 4, 2015 - 3 minutesmins - By Dani Bancroft

peter Llewellyn Davies medigene interview

News and Trends 3 Nov 2015

Exclusive from BIO-Europe 2015: Interview of Peter Llewellyn-Davies, CFO at Medigene, Munich-based Immunotherapy Biotech

This is the third interview we publish from BIO (yes, we are working hard). It comes after the interview of Simon Moroney, CEO of MorphoSys and Jane Dancer, CBO of F-star. Medigene is another big/famous Biotech company of Munich, Germany. It was founded over 20 years ago and is now specialised in cell-based therapies. It counts […]

November 3, 2015 - 1 minutemin - By Philip Hemme

News and Trends 3 Nov 2015

€100 Million Investment Round Prepares CureVac For Vaccine Expansion

“The RNA People” at CureVac in Tübingen (Germany) have a new €100M investment into their RNA platform, which has prophylactic purposes for common viruses, pipeline candidates for prostate cancer, lung cancer and research into vaccines for HIV, Tuborculosis and Rabies. Indeed, the financial success surrounding their mRNA work has been startlingly impressive, with the EU […]

November 3, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 3 Nov 2015

History of Biotech: 25 Years of The Human Genome Project

The birth of the Human Genome Project was now 25 years ago (woah!)…What was the HGP’s significance to biotech? What? The Human Genome Project (HGP) was an international effort with a primary goal; to sequence the entire genetic code of a whole organism (Humans…). It today remains the largest ever world collaborative project, which thrust the […]

November 3, 2015 - 5 minutesmins - By Marie Godar

interview simon moroney labiotech bio europe

News and Trends 2 Nov 2015

Exclusive from BIO-Europe 2015: Interview of Simon Moroney, CEO of leading German Biotech MorphoSys

BIO-Europe is also a great opportunity to meet with top people from EU’s Biotech ecosystem. I had the chance to interview Simon Moroney, the CEO and one of the founders of MorphoSys (part of our top 9 EU-based billion euros Biotechs). The Munich-based company was founded in 1992 and now counts +-350 employees for a market […]

November 2, 2015 - 1 minutemin - By Philip Hemme

News and Trends 2 Nov 2015

How Big can be Small in Biotech – #BIO-Europe 2015 Keynote

As usual at BIO-Europe, the fair starts with an opening keynote, this time with speakers from Merck Healthcare, MedImmune/AstraZeneca and Baxalta. The keynote is basically a discussion between high-level speakers, akin to the talk which took place in Paris during March, when Antoine Papiernik (the prominent European VC from Sofinnova) led a panel discussion with […]

November 2, 2015 - 5 minutesmins - By Philip Hemme

News and Trends 2 Nov 2015

EU’s biggest Biotech Fair, BIO-Europe 2015, is starting … NOW!

The European ecosystem of Biotech will be for the next three days in Munich, Germany. That’s where the BIO-Europe 2015 convention takes place. Yesterday, with Joachim and Will, we drove south from Berlin to Munich to be on-site for the start of the event. This morning, the alarm was set up early and we had to […]

November 2, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 19 Oct 2015

Secret Shareholder racks up another €19.2M for Affimed’s Cancer Tandem Antibodies

Affimed Therapeutics is a clinical-stage biopharmaceutical company from Heidelberg (Germany) which is developing highly targeted cancer immunotherapies for some leukemias and Hodgkin’s Lymphoma. An undisclosed shareholder has just increased its position in the company by purchasing an additional 3.3 million shares, leading to a total of €19.2M private investment. Affimed Therapeutics is a NASDAQ-listed biotech […]

October 19, 2015 - 2 minutesmins - By Julie Lellouche

News and Trends 16 Oct 2015

Bavarian Facility can now grow Global Strains of Algae for Aerospace Biofuel Production

The Technology University of Munich (TU München) has built a unique global-climate simulating Algal plant on the Ludwig Bölkow Campus in Ottobrunn (Bavaria). Able to cultivate algal strains from all over the world, the research team hopes this will allow them to study and discover new types to be exploited by Biotechs for biofuel production, […]

October 16, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 16 Oct 2015

Biotech of the week: Mologen, the Largest Publicly-listed Biotech of Berlin

This week, we’re leaving Paris and heading East to a city that’s 9 times bigger than the capital of France, it’s also the city we all call home here at Labiotech, Berlin. When someone thinks of Berlin, they think of the wall, the Fernsehturm (television tower) and its amazing nightlife (I can personally agree with this 😉 […]

October 16, 2015 - 2 minutesmins - By Philip Hemme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Germany

German Bioinformatics Start-Up wants to Change Studies of GMO Crops

Damn, that was BIO-Europe 2015 in Munich!

€1.37Bn Deal for Sanofi with Germany’s Fastest Growing mRNA Cancer Biotech

Exclusive from BIO-Europe 2015: Interview of Peter Llewellyn-Davies, CFO at Medigene, Munich-based Immunotherapy Biotech

€100 Million Investment Round Prepares CureVac For Vaccine Expansion

History of Biotech: 25 Years of The Human Genome Project

Exclusive from BIO-Europe 2015: Interview of Simon Moroney, CEO of leading German Biotech MorphoSys

How Big can be Small in Biotech – #BIO-Europe 2015 Keynote

EU’s biggest Biotech Fair, BIO-Europe 2015, is starting … NOW!

Secret Shareholder racks up another €19.2M for Affimed’s Cancer Tandem Antibodies

Bavarian Facility can now grow Global Strains of Algae for Aerospace Biofuel Production

Biotech of the week: Mologen, the Largest Publicly-listed Biotech of Berlin

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!